Molecular Weight:   | 198.08 |
Volume:   | 205.404 |
LogP:   | 1.533 |
LogD:   | 1.452 |
LogS:   | -3.21 |
# Rotatable Bonds:   | 0 |
TPSA:   | 48.65 |
# H-Bond Aceptor:   | 3 |
# H-Bond Donor:   | 2 |
# Rings:   | 3 |
# Heavy Atoms:   | 3 |
QED Drug-Likeness Score:   | 0.572 |
Synthetic Accessibility Score:   | 2.784 |
Fsp3:   | 0.083 |
Lipinski Rule-of-5:   | Accepted |
Pfizer Rule:   | Accepted |
GSK Rule:   | Accepted |
BMS Rule:   | 0 |
Golden Triangle Rule:   | Rejected |
Chelating Alert:   | 0 |
PAINS Alert:   | 0 |
Caco-2 Permeability:   | -4.948 |
MDCK Permeability:   | 7.245324468385661e-06 |
Pgp-inhibitor:   | 0.001 |
Pgp-substrate:   | 0.726 |
Human Intestinal Absorption (HIA):   | 0.013 |
20% Bioavailability (F20%):   | 0.687 |
30% Bioavailability (F30%):   | 0.24 |
Blood-Brain-Barrier Penetration (BBB):   | 0.787 |
Plasma Protein Binding (PPB):   | 74.28522491455078% |
Volume Distribution (VD):   | 1.0 |
Pgp-substrate:   | 17.941516876220703% |
CYP1A2-inhibitor:   | 0.987 |
CYP1A2-substrate:   | 0.947 |
CYP2C19-inhibitor:   | 0.698 |
CYP2C19-substrate:   | 0.083 |
CYP2C9-inhibitor:   | 0.233 |
CYP2C9-substrate:   | 0.783 |
CYP2D6-inhibitor:   | 0.786 |
CYP2D6-substrate:   | 0.865 |
CYP3A4-inhibitor:   | 0.522 |
CYP3A4-substrate:   | 0.215 |
Clearance (CL):   | 5.826 |
Half-life (T1/2):   | 0.622 |
hERG Blockers:   | 0.025 |
Human Hepatotoxicity (H-HT):   | 0.734 |
Drug-inuced Liver Injury (DILI):   | 0.931 |
AMES Toxicity:   | 0.824 |
Rat Oral Acute Toxicity:   | 0.948 |
Maximum Recommended Daily Dose:   | 0.902 |
Skin Sensitization:   | 0.903 |
Carcinogencity:   | 0.49 |
Eye Corrosion:   | 0.037 |
Eye Irritation:   | 0.966 |
Respiratory Toxicity:   | 0.982 |
Natural Product ID:   | NPC291389 |
Common Name*:   | Harmol |
IUPAC Name:   | 1-methyl-2,9-dihydropyrido[3,4-b]indol-7-one |
Synonyms:   | Harmol |
Standard InCHIKey:   | LBBJNGFCXDOYMQ-UHFFFAOYSA-N |
Standard InCHI:   | InChI=1S/C12H10N2O/c1-7-12-10(4-5-13-7)9-3-2-8(15)6-11(9)14-12/h2-6,13-14H,1H3 |
SMILES:   | O=c1ccc2c(c1)[nH]c1c2cc[nH]c1C |
Synthetic Gene Cluster:   | n.a. |
ChEMBL Identifier:   | CHEMBL486817 |
PubChem CID:   |
68094 |
Chemical Classification**:   |
|
*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.
Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO7395 | Tribulus terrestris | Species | Zygophyllaceae | Eukaryota | Fruits | n.a. | n.a. |
PMID[11141122] |
NPO15095 | Hippophae rhamnoides | Species | Elaeagnaceae | Eukaryota | n.a. | fruit | n.a. |
PMID[16417304] |
NPO15095 | Hippophae rhamnoides | Species | Elaeagnaceae | Eukaryota | n.a. | branch | n.a. |
PMID[17202693] |
NPO10540 | Passiflora incarnata | Species | Passifloraceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[2026709] |
NPO10856 | Passiflora edulis | Species | Passifloraceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[21608987] |
NPO1085 | Peganum harmala | Species | Nitrariaceae | Eukaryota | Seeds | n.a. | n.a. |
PMID[28128938] |
NPO1085 | Peganum harmala | Species | Nitrariaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[6736972] |
NPO10856 | Passiflora edulis | Species | Passifloraceae | Eukaryota | Seed | n.a. | n.a. | Database[FooDB] |
NPO15095 | Hippophae rhamnoides | Species | Elaeagnaceae | Eukaryota | n.a. | n.a. | Database[FooDB] | |
NPO10856 | Passiflora edulis | Species | Passifloraceae | Eukaryota | n.a. | n.a. | Database[FooDB] | |
NPO10856 | Passiflora edulis | Species | Passifloraceae | Eukaryota | n.a. | n.a. | Database[FooDB] | |
NPO15095 | Hippophae rhamnoides | Species | Elaeagnaceae | Eukaryota | Bark | n.a. | n.a. | Database[FooDB] |
NPO15095 | Hippophae rhamnoides | Species | Elaeagnaceae | Eukaryota | Fruit | n.a. | n.a. | Database[FooDB] |
NPO10856 | Passiflora edulis | Species | Passifloraceae | Eukaryota | Fruit | n.a. | n.a. | Database[FooDB] |
NPO10856 | Passiflora edulis | Species | Passifloraceae | Eukaryota | Fruit Juice | n.a. | n.a. | Database[FooDB] |
NPO15095 | Hippophae rhamnoides | Species | Elaeagnaceae | Eukaryota | Leaf | n.a. | n.a. | Database[FooDB] |
NPO15095 | Hippophae rhamnoides | Species | Elaeagnaceae | Eukaryota | Root | n.a. | n.a. | Database[FooDB] |
NPO15095 | Hippophae rhamnoides | Species | Elaeagnaceae | Eukaryota | Seed | n.a. | n.a. | Database[FooDB] |
NPO18460 | Trema dielsiana | Species | Cannabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO7395 | Tribulus terrestris | Species | Zygophyllaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO15095 | Hippophae rhamnoides | Species | Elaeagnaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO7780 | Thalictrum foetidum | Species | Ranunculaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO3808 | Elaeagnus angustifolia | Species | Elaeagnaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO10540 | Passiflora incarnata | Species | Passifloraceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO1085 | Peganum harmala | Species | Nitrariaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO10856 | Passiflora edulis | Species | Passifloraceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO10856 | Passiflora edulis | Species | Passifloraceae | Eukaryota | Fruits | n.a. | Database[Phenol-Explorer] | |
NPO18460 | Trema dielsiana | Species | Cannabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO10856 | Passiflora edulis | Species | Passifloraceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO7780 | Thalictrum foetidum | Species | Ranunculaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO3808 | Elaeagnus angustifolia | Species | Elaeagnaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO1085 | Peganum harmala | Species | Nitrariaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO15095 | Hippophae rhamnoides | Species | Elaeagnaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO10540 | Passiflora incarnata | Species | Passifloraceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO7395 | Tribulus terrestris | Species | Zygophyllaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO7395 | Tribulus terrestris | Species | Zygophyllaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCM_Taiwan] |
NPO1085 | Peganum harmala | Species | Nitrariaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCM_Taiwan] |
NPO15095 | Hippophae rhamnoides | Species | Elaeagnaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCM_Taiwan] |
NPO3808 | Elaeagnus angustifolia | Species | Elaeagnaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCM_Taiwan] |
NPO15095 | Hippophae rhamnoides | Species | Elaeagnaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TM-MC] |
NPO7395 | Tribulus terrestris | Species | Zygophyllaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TM-MC] |
NPO3808 | Elaeagnus angustifolia | Species | Elaeagnaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO1085 | Peganum harmala | Species | Nitrariaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO10856 | Passiflora edulis | Species | Passifloraceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO18460 | Trema dielsiana | Species | Cannabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO7780 | Thalictrum foetidum | Species | Ranunculaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO15095 | Hippophae rhamnoides | Species | Elaeagnaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO7395 | Tribulus terrestris | Species | Zygophyllaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO10540 | Passiflora incarnata | Species | Passifloraceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
☉ UNPD: Universal Natural Products Database [PMID: 23638153].
☉ StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
☉ TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
☉ TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
☉ TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
☉ TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
☉ HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
☉ MetaboLights: a metabolomics database [PMID: 27010336].
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].
Organism ID | NP ID | Organism Material Preparation | Organism Part | NP Quantity (Standard) | NP Quantity (Minimum) | NP Quantity (Maximum) | Quantity Unit | Reference |
---|
☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
☉ DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
☉ PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT110 | Individual Protein | Cytochrome P450 2D6 | Homo sapiens | Ki | = | 65000.0 | nM | PMID[547052] |
NPT91 | Cell Line | KB | Homo sapiens | ED50 | = | 4.4 | ug ml-1 | PMID[547053] |
NPT81 | Cell Line | A549 | Homo sapiens | ED50 | = | 6.5 | ug ml-1 | PMID[547053] |
NPT308 | Cell Line | CAKI-1 | Homo sapiens | ED50 | = | 9.2 | ug ml-1 | PMID[547053] |
NPT83 | Cell Line | MCF7 | Homo sapiens | ED50 | = | 9.2 | ug ml-1 | PMID[547053] |
NPT309 | Cell Line | 1A9 | Homo sapiens | ED50 | = | 3.8 | ug ml-1 | PMID[547053] |
NPT1535 | Cell Line | U-87 MG | Homo sapiens | ED50 | = | 4.2 | ug ml-1 | PMID[547053] |
NPT3240 | Individual Protein | Cyclin-dependent kinase 5 | Homo sapiens | Inhibition | = | 72.0 | % | PMID[547054] |
NPT1371 | Individual Protein | Cyclin-dependent kinase 2 | Homo sapiens | Inhibition | = | 69.0 | % | PMID[547054] |
NPT759 | Cell Line | H9 | Homo sapiens | IC50 | = | 108100.0 | nM | PMID[547055] |
NPT483 | Individual Protein | Prelamin-A/C | Homo sapiens | Potency | = | 7.9 | nM | PMID[547056] |
NPT149 | Individual Protein | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Homo sapiens | Potency | = | 31622.8 | nM | PMID[547057] |
NPT48 | Individual Protein | Lysine-specific demethylase 4D-like | Homo sapiens | Potency | = | 35481.3 | nM | PMID[547057] |
NPT48 | Individual Protein | Lysine-specific demethylase 4D-like | Homo sapiens | Potency | = | 28183.8 | nM | PMID[547056] |
NPT1038 | Individual Protein | Histone-lysine N-methyltransferase MLL | Homo sapiens | Potency | = | 8912.5 | nM | PMID[547056] |
NPT213 | Individual Protein | Cytochrome P450 2C19 | Homo sapiens | Potency | = | 25118.9 | nM | PMID[547058] |
NPT442 | Individual Protein | Ferritin light chain | Equus caballus | Potency | = | 28183.8 | nM | PMID[547056] |
NPT150 | Individual Protein | Anthrax lethal factor | Bacillus anthracis | Potency | = | 12589.3 | nM | PMID[547058] |
NPT151 | Individual Protein | 15-hydroxyprostaglandin dehydrogenase [NAD+] | Homo sapiens | Potency | = | 35481.3 | nM | PMID[547057] |
NPT501 | Individual Protein | Alpha-galactosidase A | Homo sapiens | Potency | = | 39810.7 | nM | PMID[547056] |
NPT501 | Individual Protein | Alpha-galactosidase A | Homo sapiens | Potency | = | 44668.4 | nM | PMID[547057] |
NPT149 | Individual Protein | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Homo sapiens | Potency | = | 31622.8 | nM | PMID[547058] |
NPT539 | Individual Protein | Cellular tumor antigen p53 | Homo sapiens | Potency | = | 25118.9 | nM | PMID[547057] |
NPT59 | Individual Protein | DNA polymerase beta | Homo sapiens | Potency | = | 28183.8 | nM | PMID[547056] |
NPT109 | Individual Protein | Cytochrome P450 3A4 | Homo sapiens | Potency | = | 39810.7 | nM | PMID[547057] |
NPT110 | Individual Protein | Cytochrome P450 2D6 | Homo sapiens | Potency | = | 15848.9 | nM | PMID[547058] |
NPT212 | Individual Protein | Cytochrome P450 2C9 | Homo sapiens | Potency | = | 15848.9 | nM | PMID[547058] |
NPT61 | Individual Protein | Beta-glucocerebrosidase | Homo sapiens | Potency | n.a. | 19952.6 | nM | PMID[547056] |
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | n.a. | 8199.5 | nM | PMID[547056] |
NPT64 | Individual Protein | ATPase family AAA domain-containing protein 5 | Homo sapiens | Potency | n.a. | 5802.4 | nM | PMID[547056] |
NPT5 | Individual Protein | Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 | Homo sapiens | Potency | n.a. | 50118.7 | nM | PMID[547056] |
NPT65 | Cell Line | HepG2 | Homo sapiens | Potency | n.a. | 17782.8 | nM | PMID[547056] |
NPT1078 | Individual Protein | Indoleamine 2,3-dioxygenase | Homo sapiens | IC50 | = | 2000000.0 | nM | PMID[547059] |
NPT4093 | Individual Protein | Serine/threonine-protein kinase haspin | Homo sapiens | IC50 | = | 770.0 | nM | PMID[547060] |
NPT3399 | Individual Protein | Dual-specificity tyrosine-phosphorylation regulated kinase 2 | Homo sapiens | IC50 | = | 1500.0 | nM | PMID[547060] |
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | n.a. | 29092.9 | nM | PMID[547056] |
NPT1852 | Individual Protein | Rac GTPase-activating protein 1 | Homo sapiens | IC50 | n.a. | 44910.0 | nM | PMID[547056] |
NPT5016 | Individual Protein | DNA repair and recombination protein RAD54-like | Homo sapiens | AC50 | n.a. | 23890.0 | nM | PMID[547056] |
NPT1417 | Individual Protein | Transcriptional regulator ERG | Homo sapiens | Potency | n.a. | 112201.8 | nM | PMID[547056] |
NPT156 | Individual Protein | Sphingomyelin phosphodiesterase | Homo sapiens | Potency | n.a. | 25118.9 | nM | PMID[547056] |
NPT1417 | Individual Protein | Transcriptional regulator ERG | Homo sapiens | Potency | n.a. | 44668.4 | nM | PMID[547056] |
NPT1043 | Individual Protein | Glycoprotein hormones alpha chain | Homo sapiens | Potency | n.a. | 1584.9 | nM | PMID[547056] |
NPT50 | Individual Protein | Tyrosyl-DNA phosphodiesterase 1 | Homo sapiens | Potency | n.a. | 13335.9 | nM | PMID[547061] |
NPT50 | Individual Protein | Tyrosyl-DNA phosphodiesterase 1 | Homo sapiens | Potency | n.a. | 14581.0 | nM | PMID[547056] |
NPT50 | Individual Protein | Tyrosyl-DNA phosphodiesterase 1 | Homo sapiens | Potency | n.a. | 20596.2 | nM | PMID[547056] |
NPT50 | Individual Protein | Tyrosyl-DNA phosphodiesterase 1 | Homo sapiens | Potency | n.a. | 23715.0 | nM | PMID[547061] |
NPT49 | Individual Protein | DNA-(apurinic or apyrimidinic site) lyase | Homo sapiens | Potency | n.a. | 28183.8 | nM | PMID[547056] |
NPT49 | Individual Protein | DNA-(apurinic or apyrimidinic site) lyase | Homo sapiens | Potency | n.a. | 35481.3 | nM | PMID[547057] |
NPT3575 | Individual Protein | Chitinase | Onchocerca volvulus | IC50 | = | 7080.0 | nM | PMID[547062] |
NPT24 | Organism | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | EC50 | = | 11100.0 | nM | PMID[547055] |
NPT27 | Others | Unspecified | Ratio IC50/EC50 | = | 9.7 | uM | PMID[547055] | |
NPT2 | Others | Unspecified | Potency | = | 10000.0 | nM | PMID[547057] | |
NPT536 | Uncleic Acid | microRNA 21 | Homo sapiens | Potency | = | 13091.8 | nM | PMID[547056] |
NPT791 | Individual Protein | Cruzipain | Trypanosoma cruzi | Potency | = | 39810.7 | nM | PMID[547057] |
NPT94 | Individual Protein | Aldehyde dehydrogenase 1A1 | Homo sapiens | Potency | = | 31622.8 | nM | PMID[547056] |
NPT94 | Individual Protein | Aldehyde dehydrogenase 1A1 | Homo sapiens | Potency | = | 31622.8 | nM | PMID[547057] |
NPT2 | Others | Unspecified | Potency | = | 794.3 | nM | PMID[547057] | |
NPT2 | Others | Unspecified | Potency | n.a. | 35481.3 | nM | PMID[547056] | |
NPT533 | Protein-Protein Interaction | Runt-related transcription factor 1/Core-binding factor subunit beta | Homo sapiens | Potency | n.a. | 5623.4 | nM | PMID[547057] |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | n.a. | 10417.9 | nM | PMID[547056] |
NPT7 | Individual Protein | Thioredoxin reductase 1, cytoplasmic | Rattus norvegicus | Potency | n.a. | 39810.7 | nM | PMID[547056] |
NPT84 | Individual Protein | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | Rattus norvegicus | AC50 | = | 298.0 | nM | PMID[547056] |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | n.a. | 13115.4 | nM | PMID[547056] |
NPT2 | Others | Unspecified | Potency | n.a. | 7079.5 | nM | PMID[547056] | |
NPT7 | Individual Protein | Thioredoxin reductase 1, cytoplasmic | Rattus norvegicus | Potency | n.a. | 25118.9 | nM | PMID[547056] |
NPT2 | Others | Unspecified | IC50 | n.a. | 61920.0 | nM | PMID[547056] | |
NPT2 | Others | Unspecified | Potency | n.a. | 16360.1 | nM | PMID[547056] | |
NPT861 | Individual Protein | Isocitrate dehydrogenase [NADP] cytoplasmic | Homo sapiens | Potency | n.a. | 8199.5 | nM | PMID[547056] |
NPT2 | Others | Unspecified | Potency | n.a. | 11220.2 | nM | PMID[547056] | |
NPT2 | Others | Unspecified | AC50 | = | 22110.0 | nM | PMID[547056] | |
NPT2 | Others | Unspecified | Potency | n.a. | 25118.9 | nM | PMID[547061] | |
NPT3576 | Organism | Onchocerca volvulus | Onchocerca volvulus | Inhibition | = | 61.0 | % | PMID[547062] |
☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.
Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC291389 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.7292 | Intermediate Similarity | NPC471655 |
0.6918 | Remote Similarity | NPC100726 |
0.6887 | Remote Similarity | NPC474492 |
0.6842 | Remote Similarity | NPC470680 |
0.6842 | Remote Similarity | NPC100104 |
0.6812 | Remote Similarity | NPC22079 |
0.6781 | Remote Similarity | NPC467188 |
0.6752 | Remote Similarity | NPC262338 |
0.6738 | Remote Similarity | NPC291517 |
0.6689 | Remote Similarity | NPC105811 |
0.6667 | Remote Similarity | NPC470440 |
0.6644 | Remote Similarity | NPC123906 |
0.6644 | Remote Similarity | NPC190296 |
0.6643 | Remote Similarity | NPC125746 |
0.6573 | Remote Similarity | NPC325252 |
0.6554 | Remote Similarity | NPC314372 |
0.6533 | Remote Similarity | NPC102664 |
0.6528 | Remote Similarity | NPC84911 |
0.6513 | Remote Similarity | NPC251391 |
0.6513 | Remote Similarity | NPC281094 |
0.6503 | Remote Similarity | NPC79777 |
0.6503 | Remote Similarity | NPC198988 |
0.6497 | Remote Similarity | NPC233380 |
0.649 | Remote Similarity | NPC473878 |
0.6483 | Remote Similarity | NPC104049 |
0.6481 | Remote Similarity | NPC284775 |
0.6471 | Remote Similarity | NPC75135 |
0.6471 | Remote Similarity | NPC209362 |
0.646 | Remote Similarity | NPC186068 |
0.6458 | Remote Similarity | NPC261195 |
0.6458 | Remote Similarity | NPC29886 |
0.6458 | Remote Similarity | NPC96102 |
0.6447 | Remote Similarity | NPC70406 |
0.6443 | Remote Similarity | NPC159856 |
0.6438 | Remote Similarity | NPC110126 |
0.6438 | Remote Similarity | NPC73767 |
0.6433 | Remote Similarity | NPC274981 |
0.6429 | Remote Similarity | NPC169586 |
0.6424 | Remote Similarity | NPC37548 |
0.6414 | Remote Similarity | NPC105127 |
0.6402 | Remote Similarity | NPC234403 |
0.64 | Remote Similarity | NPC143872 |
0.6395 | Remote Similarity | NPC469768 |
0.6395 | Remote Similarity | NPC238499 |
0.6395 | Remote Similarity | NPC469783 |
0.6395 | Remote Similarity | NPC469779 |
0.6395 | Remote Similarity | NPC469784 |
0.6395 | Remote Similarity | NPC469780 |
0.6395 | Remote Similarity | NPC469767 |
0.6395 | Remote Similarity | NPC469761 |
0.6392 | Remote Similarity | NPC115232 |
0.6389 | Remote Similarity | NPC23215 |
0.6387 | Remote Similarity | NPC213914 |
0.6382 | Remote Similarity | NPC24678 |
0.6382 | Remote Similarity | NPC105818 |
0.6376 | Remote Similarity | NPC242556 |
0.6369 | Remote Similarity | NPC282231 |
0.6364 | Remote Similarity | NPC229055 |
0.6358 | Remote Similarity | NPC471957 |
0.6351 | Remote Similarity | NPC469766 |
0.635 | Remote Similarity | NPC41174 |
0.6345 | Remote Similarity | NPC218268 |
0.634 | Remote Similarity | NPC217021 |
0.634 | Remote Similarity | NPC470679 |
0.6329 | Remote Similarity | NPC271797 |
0.6329 | Remote Similarity | NPC21174 |
0.6323 | Remote Similarity | NPC74357 |
0.6316 | Remote Similarity | NPC187951 |
0.6306 | Remote Similarity | NPC279918 |
0.6303 | Remote Similarity | NPC477042 |
0.6299 | Remote Similarity | NPC200214 |
0.6299 | Remote Similarity | NPC469765 |
0.6299 | Remote Similarity | NPC469760 |
0.6299 | Remote Similarity | NPC469763 |
0.6299 | Remote Similarity | NPC469786 |
0.6299 | Remote Similarity | NPC259644 |
0.6299 | Remote Similarity | NPC73952 |
0.6299 | Remote Similarity | NPC25008 |
0.6294 | Remote Similarity | NPC82295 |
0.6289 | Remote Similarity | NPC42372 |
0.6286 | Remote Similarity | NPC250361 |
0.6284 | Remote Similarity | NPC115611 |
0.6284 | Remote Similarity | NPC2949 |
0.6284 | Remote Similarity | NPC279081 |
0.6284 | Remote Similarity | NPC59084 |
0.6275 | Remote Similarity | NPC313889 |
0.6273 | Remote Similarity | NPC471943 |
0.6272 | Remote Similarity | NPC474259 |
0.6272 | Remote Similarity | NPC23476 |
0.6272 | Remote Similarity | NPC477415 |
0.6268 | Remote Similarity | NPC473587 |
0.6265 | Remote Similarity | NPC191415 |
0.6259 | Remote Similarity | NPC27740 |
0.6258 | Remote Similarity | NPC70922 |
0.6258 | Remote Similarity | NPC212376 |
0.6258 | Remote Similarity | NPC211572 |
0.6258 | Remote Similarity | NPC293216 |
0.6258 | Remote Similarity | NPC75540 |
0.6258 | Remote Similarity | NPC80597 |
0.6258 | Remote Similarity | NPC470507 |
0.6258 | Remote Similarity | NPC38736 |
0.625 | Remote Similarity | NPC49954 |
0.625 | Remote Similarity | NPC474561 |
0.6242 | Remote Similarity | NPC63157 |
0.6242 | Remote Similarity | NPC473868 |
0.6235 | Remote Similarity | NPC6982 |
0.6235 | Remote Similarity | NPC470498 |
0.6224 | Remote Similarity | NPC475428 |
0.6221 | Remote Similarity | NPC47190 |
0.6218 | Remote Similarity | NPC285469 |
0.6216 | Remote Similarity | NPC88097 |
0.6209 | Remote Similarity | NPC321911 |
0.6209 | Remote Similarity | NPC124005 |
0.6205 | Remote Similarity | NPC182940 |
0.6198 | Remote Similarity | NPC196580 |
0.6197 | Remote Similarity | NPC473762 |
0.619 | Remote Similarity | NPC477003 |
0.6188 | Remote Similarity | NPC2414 |
0.6184 | Remote Similarity | NPC129042 |
0.6184 | Remote Similarity | NPC288838 |
0.6182 | Remote Similarity | NPC473380 |
0.6182 | Remote Similarity | NPC240088 |
0.6181 | Remote Similarity | NPC179365 |
0.6181 | Remote Similarity | NPC475450 |
0.6178 | Remote Similarity | NPC299594 |
0.6176 | Remote Similarity | NPC473946 |
0.6174 | Remote Similarity | NPC230002 |
0.6173 | Remote Similarity | NPC194411 |
0.6169 | Remote Similarity | NPC53947 |
0.6164 | Remote Similarity | NPC214106 |
0.6154 | Remote Similarity | NPC471458 |
0.6154 | Remote Similarity | NPC477815 |
0.6154 | Remote Similarity | NPC280290 |
0.6149 | Remote Similarity | NPC54988 |
0.6148 | Remote Similarity | NPC476566 |
0.6145 | Remote Similarity | NPC11126 |
0.6145 | Remote Similarity | NPC265710 |
0.6144 | Remote Similarity | NPC179787 |
0.6144 | Remote Similarity | NPC469811 |
0.6144 | Remote Similarity | NPC201380 |
0.6139 | Remote Similarity | NPC135141 |
0.6139 | Remote Similarity | NPC92796 |
0.6139 | Remote Similarity | NPC318065 |
0.6139 | Remote Similarity | NPC206819 |
0.6133 | Remote Similarity | NPC114033 |
0.6133 | Remote Similarity | NPC277157 |
0.6133 | Remote Similarity | NPC101130 |
0.6133 | Remote Similarity | NPC58268 |
0.6133 | Remote Similarity | NPC129412 |
0.6129 | Remote Similarity | NPC216713 |
0.6125 | Remote Similarity | NPC311276 |
0.6125 | Remote Similarity | NPC194640 |
0.6125 | Remote Similarity | NPC478184 |
0.6122 | Remote Similarity | NPC292434 |
0.6122 | Remote Similarity | NPC200397 |
0.6122 | Remote Similarity | NPC167200 |
0.6122 | Remote Similarity | NPC64661 |
0.6122 | Remote Similarity | NPC14448 |
0.6122 | Remote Similarity | NPC195704 |
0.6122 | Remote Similarity | NPC138596 |
0.6122 | Remote Similarity | NPC98156 |
0.6121 | Remote Similarity | NPC151635 |
0.6118 | Remote Similarity | NPC204141 |
0.6115 | Remote Similarity | NPC469785 |
0.6115 | Remote Similarity | NPC141353 |
0.6114 | Remote Similarity | NPC472293 |
0.6111 | Remote Similarity | NPC63751 |
0.6108 | Remote Similarity | NPC16659 |
0.6105 | Remote Similarity | NPC324091 |
0.6105 | Remote Similarity | NPC475874 |
0.6095 | Remote Similarity | NPC21429 |
0.6092 | Remote Similarity | NPC473821 |
0.609 | Remote Similarity | NPC232798 |
0.6087 | Remote Similarity | NPC71132 |
0.608 | Remote Similarity | NPC74153 |
0.608 | Remote Similarity | NPC167710 |
0.6078 | Remote Similarity | NPC478186 |
0.6078 | Remote Similarity | NPC63545 |
0.6076 | Remote Similarity | NPC286427 |
0.6076 | Remote Similarity | NPC469762 |
0.6076 | Remote Similarity | NPC76982 |
0.6074 | Remote Similarity | NPC65080 |
0.6071 | Remote Similarity | NPC470677 |
0.6069 | Remote Similarity | NPC476460 |
0.6065 | Remote Similarity | NPC148592 |
0.6062 | Remote Similarity | NPC16667 |
0.6061 | Remote Similarity | NPC37423 |
0.6061 | Remote Similarity | NPC275305 |
0.6059 | Remote Similarity | NPC133003 |
0.6059 | Remote Similarity | NPC474258 |
0.6057 | Remote Similarity | NPC157828 |
0.6057 | Remote Similarity | NPC195239 |
0.6057 | Remote Similarity | NPC202812 |
0.6051 | Remote Similarity | NPC207726 |
0.6048 | Remote Similarity | NPC233050 |
0.6048 | Remote Similarity | NPC276540 |
0.6047 | Remote Similarity | NPC473628 |
0.6039 | Remote Similarity | NPC21605 |
0.6038 | Remote Similarity | NPC475990 |
0.6038 | Remote Similarity | NPC293487 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC291389 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.6458 | Remote Similarity | NPD198 | Clinical (unspecified phase) |
0.6438 | Remote Similarity | NPD786 | Approved |
0.6424 | Remote Similarity | NPD3100 | Discontinued |
0.6382 | Remote Similarity | NPD4463 | Approved |
0.6382 | Remote Similarity | NPD4462 | Approved |
0.6351 | Remote Similarity | NPD1722 | Approved |
0.6346 | Remote Similarity | NPD2214 | Approved |
0.6346 | Remote Similarity | NPD2213 | Approved |
0.6335 | Remote Similarity | NPD3347 | Clinical (unspecified phase) |
0.6316 | Remote Similarity | NPD4374 | Clinical (unspecified phase) |
0.6316 | Remote Similarity | NPD269 | Clinical (unspecified phase) |
0.6303 | Remote Similarity | NPD1291 | Clinical (unspecified phase) |
0.6287 | Remote Similarity | NPD3607 | Clinical (unspecified phase) |
0.6284 | Remote Similarity | NPD3943 | Clinical (unspecified phase) |
0.6242 | Remote Similarity | NPD5020 | Approved |
0.622 | Remote Similarity | NPD4075 | Phase 2 |
0.6174 | Remote Similarity | NPD9599 | Approved |
0.6159 | Remote Similarity | NPD5254 | Discontinued |
0.6138 | Remote Similarity | NPD1627 | Clinical (unspecified phase) |
0.6133 | Remote Similarity | NPD3834 | Clinical (unspecified phase) |
0.6108 | Remote Similarity | NPD5473 | Discontinued |
0.6107 | Remote Similarity | NPD569 | Clinical (unspecified phase) |
0.6103 | Remote Similarity | NPD9392 | Approved |
0.6103 | Remote Similarity | NPD9396 | Approved |
0.6065 | Remote Similarity | NPD2172 | Phase 1 |
0.6036 | Remote Similarity | NPD3318 | Approved |
0.6036 | Remote Similarity | NPD3320 | Approved |
0.6036 | Remote Similarity | NPD3319 | Phase 1 |
0.6026 | Remote Similarity | NPD1592 | Phase 3 |
0.6023 | Remote Similarity | NPD4426 | Clinical (unspecified phase) |
0.6014 | Remote Similarity | NPD992 | Clinical (unspecified phase) |
0.6014 | Remote Similarity | NPD991 | Phase 2 |
0.5988 | Remote Similarity | NPD3506 | Approved |
0.5988 | Remote Similarity | NPD3505 | Approved |
0.5987 | Remote Similarity | NPD4637 | Clinical (unspecified phase) |
0.5977 | Remote Similarity | NPD6180 | Clinical (unspecified phase) |
0.5973 | Remote Similarity | NPD1262 | Discovery |
0.5964 | Remote Similarity | NPD4128 | Approved |
0.5952 | Remote Similarity | NPD4076 | Approved |
0.5952 | Remote Similarity | NPD4079 | Approved |
0.5946 | Remote Similarity | NPD272 | Approved |
0.5935 | Remote Similarity | NPD1270 | Approved |
0.593 | Remote Similarity | NPD6217 | Discontinued |
0.5929 | Remote Similarity | NPD268 | Approved |
0.5929 | Remote Similarity | NPD271 | Approved |
0.5929 | Remote Similarity | NPD9598 | Discontinued |
0.5929 | Remote Similarity | NPD270 | Clinical (unspecified phase) |
0.5928 | Remote Similarity | NPD749 | Clinical (unspecified phase) |
0.5915 | Remote Similarity | NPD9357 | Approved |
0.5915 | Remote Similarity | NPD5069 | Clinical (unspecified phase) |
0.5912 | Remote Similarity | NPD276 | Clinical (unspecified phase) |
0.5901 | Remote Similarity | NPD1404 | Approved |
0.5901 | Remote Similarity | NPD1403 | Approved |
0.5896 | Remote Similarity | NPD3961 | Discontinued |
0.5894 | Remote Similarity | NPD768 | Clinical (unspecified phase) |
0.589 | Remote Similarity | NPD3476 | Approved |
0.589 | Remote Similarity | NPD3475 | Approved |
0.589 | Remote Similarity | NPD2915 | Discontinued |
0.589 | Remote Similarity | NPD5744 | Clinical (unspecified phase) |
0.5887 | Remote Similarity | NPD5787 | Discontinued |
0.5886 | Remote Similarity | NPD2837 | Discontinued |
0.5879 | Remote Similarity | NPD1326 | Approved |
0.5879 | Remote Similarity | NPD1325 | Approved |
0.5879 | Remote Similarity | NPD4184 | Clinical (unspecified phase) |
0.5871 | Remote Similarity | NPD1683 | Approved |
0.5868 | Remote Similarity | NPD482 | Approved |
0.5867 | Remote Similarity | NPD200 | Phase 2 |
0.5867 | Remote Similarity | NPD201 | Phase 2 |
0.5862 | Remote Similarity | NPD1031 | Discontinued |
0.586 | Remote Similarity | NPD3835 | Phase 3 |
0.586 | Remote Similarity | NPD3833 | Phase 3 |
0.5857 | Remote Similarity | NPD4811 | Discontinued |
0.585 | Remote Similarity | NPD803 | Phase 1 |
0.5833 | Remote Similarity | NPD9583 | Approved |
0.5828 | Remote Similarity | NPD5140 | Approved |
0.5828 | Remote Similarity | NPD5138 | Approved |
0.5828 | Remote Similarity | NPD3323 | Discontinued |
0.5822 | Remote Similarity | NPD3654 | Approved |
0.5818 | Remote Similarity | NPD2641 | Approved |
0.5818 | Remote Similarity | NPD2640 | Approved |
0.5811 | Remote Similarity | NPD9100 | Approved |
0.5806 | Remote Similarity | NPD175 | Clinical (unspecified phase) |
0.5805 | Remote Similarity | NPD3246 | Discontinued |
0.58 | Remote Similarity | NPD206 | Clinical (unspecified phase) |
0.58 | Remote Similarity | NPD490 | Clinical (unspecified phase) |
0.5793 | Remote Similarity | NPD2118 | Approved |
0.5793 | Remote Similarity | NPD2119 | Approved |
0.5779 | Remote Similarity | NPD2007 | Clinical (unspecified phase) |
0.5774 | Remote Similarity | NPD2928 | Phase 2 |
0.5774 | Remote Similarity | NPD5065 | Approved |
0.5772 | Remote Similarity | NPD3385 | Approved |
0.5758 | Remote Similarity | NPD2639 | Approved |
0.5758 | Remote Similarity | NPD4643 | Clinical (unspecified phase) |
0.5758 | Remote Similarity | NPD2642 | Approved |
0.5756 | Remote Similarity | NPD5728 | Clinical (unspecified phase) |
0.5754 | Remote Similarity | NPD4848 | Phase 1 |
0.574 | Remote Similarity | NPD7402 | Clinical (unspecified phase) |
0.5733 | Remote Similarity | NPD4880 | Discontinued |
0.5731 | Remote Similarity | NPD2479 | Phase 3 |
0.5731 | Remote Similarity | NPD6595 | Phase 3 |
0.5731 | Remote Similarity | NPD2481 | Approved |
0.573 | Remote Similarity | NPD460 | Discontinued |
0.5723 | Remote Similarity | NPD1343 | Approved |
0.5723 | Remote Similarity | NPD2185 | Clinical (unspecified phase) |
0.5714 | Remote Similarity | NPD4524 | Discontinued |
0.5714 | Remote Similarity | NPD4112 | Clinical (unspecified phase) |
0.5706 | Remote Similarity | NPD4181 | Approved |
0.5706 | Remote Similarity | NPD6203 | Clinical (unspecified phase) |
0.5706 | Remote Similarity | NPD2144 | Approved |
0.5706 | Remote Similarity | NPD5592 | Clinical (unspecified phase) |
0.5698 | Remote Similarity | NPD3178 | Discontinued |
0.5686 | Remote Similarity | NPD680 | Discontinued |
0.568 | Remote Similarity | NPD4736 | Clinical (unspecified phase) |
0.5677 | Remote Similarity | NPD4047 | Discontinued |
0.5674 | Remote Similarity | NPD4922 | Phase 2 |
0.5671 | Remote Similarity | NPD5400 | Approved |
0.5671 | Remote Similarity | NPD1853 | Clinical (unspecified phase) |
0.5667 | Remote Similarity | NPD4030 | Approved |
0.5667 | Remote Similarity | NPD4028 | Approved |
0.5667 | Remote Similarity | NPD4029 | Approved |
0.5665 | Remote Similarity | NPD2095 | Phase 2 |
0.5665 | Remote Similarity | NPD2094 | Phase 2 |
0.5665 | Remote Similarity | NPD2092 | Phase 2 |
0.5664 | Remote Similarity | NPD748 | Clinical (unspecified phase) |
0.5664 | Remote Similarity | NPD1561 | Phase 2 |
0.5655 | Remote Similarity | NPD3610 | Approved |
0.5655 | Remote Similarity | NPD6828 | Phase 2 |
0.5655 | Remote Similarity | NPD3609 | Approved |
0.5655 | Remote Similarity | NPD6827 | Clinical (unspecified phase) |
0.5652 | Remote Similarity | NPD2061 | Approved |
0.565 | Remote Similarity | NPD4499 | Approved |
0.565 | Remote Similarity | NPD5685 | Approved |
0.565 | Remote Similarity | NPD5686 | Approved |
0.5649 | Remote Similarity | NPD1395 | Clinical (unspecified phase) |
0.5647 | Remote Similarity | NPD5104 | Approved |
0.5645 | Remote Similarity | NPD2008 | Discontinued |
0.5644 | Remote Similarity | NPD1630 | Approved |
0.5642 | Remote Similarity | NPD1304 | Clinical (unspecified phase) |
0.5641 | Remote Similarity | NPD751 | Clinical (unspecified phase) |
0.564 | Remote Similarity | NPD1643 | Phase 3 |
0.5638 | Remote Similarity | NPD9726 | Discontinued |
0.5636 | Remote Similarity | NPD3583 | Phase 2 |
0.5633 | Remote Similarity | NPD4702 | Approved |
0.5633 | Remote Similarity | NPD4703 | Approved |
0.5632 | Remote Similarity | NPD2096 | Phase 2 |
0.5632 | Remote Similarity | NPD2091 | Phase 2 |
0.5629 | Remote Similarity | NPD5021 | Discontinued |
0.5629 | Remote Similarity | NPD2844 | Phase 3 |
0.5628 | Remote Similarity | NPD8248 | Clinical (unspecified phase) |
0.5625 | Remote Similarity | NPD9343 | Clinical (unspecified phase) |
0.5625 | Remote Similarity | NPD5590 | Clinical (unspecified phase) |
0.5625 | Remote Similarity | NPD3486 | Clinical (unspecified phase) |
0.5622 | Remote Similarity | NPD6176 | Phase 1 |
0.5621 | Remote Similarity | NPD750 | Phase 2 |
0.5615 | Remote Similarity | NPD708 | Approved |
0.5607 | Remote Similarity | NPD3038 | Discontinued |
0.5602 | Remote Similarity | NPD1568 | Clinical (unspecified phase) |
0.56 | Remote Similarity | NPD6610 | Clinical (unspecified phase) |
Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
☉ A: chemistry similarity;
☉ B: biological targets similarity;
☉ C: networks similarity;
☉ D: cell-based bioactivity similarity;
☉ E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.